Manzoor Hifza, Shahid Muhammad, Ahmed Nadeem, Afzal Samia, Huzaifa Muhammad, Tahir Saad, Amin Iram
Division of Molecular Virology and Infectious Diseases, Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan.
Bio Pharmaceutical Lab, Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan.
Viral Immunol. 2025 Oct;38(8):280-287. doi: 10.1177/08828245251382143. Epub 2025 Sep 26.
The hepatitis delta virus (HDV) is a defective and small, blood-borne viroid-like pathogen that coinfects with the hepatitis B virus (HBV) in about 5% of the infected individuals as it is a satellite virus of HBV. The treatment of HDV infection is quite challenging because there is no vaccine against HDV. Several commercial PCR and in-house assays have been developed, but there are greater variations in the results of these assays because they are not standardized properly. Studies are also delayed because of the unavailability of commercial HDV-specific antibodies for the diagnosis of HDV infection, even for the research devotions. To fill this gap, the recombinant antigenic HDAg protein of genotype I of HDV from the local isolate was successfully expressed and purified in the Escherichia coli () system, followed by anti-HDAg antibodies production in rabbits. After determining and amplifying the antigenic region of of HDV, the fragment was cloned into the pET-28a vector and expressed in TOP10 cells. Following the successful expression of recombinant protein with a His-tag at its C-terminal end, we purified the protein using affinity chromatography. Both the expression and purification of HDAg-An protein were confirmed through SDS-PAGE and Western blot analysis. Through proper optimization, the HDAg-An protein was obtained with more than 90% purity. The next step involved immunizing Japanese White rabbits with the purified . The immunization protocol included 80 µg of HDAg-An in two subcutaneous priming doses and four 40 µg booster doses, followed by blood collection two weeks after each boost to monitor antibody production. The level of anti-HDAg antibodies in the rabbit serum was assessed using a quantitative ELISA technique. In the future, these antibodies could be used for the development of HDV-specific in-house assays as well as vaccines against the HDV genotype I that is locally predominant, potentially decreasing the burden of imported diagnostic tools and reagents.
丁型肝炎病毒(HDV)是一种有缺陷的、小型的、经血传播的类病毒病原体,约5%的乙肝病毒(HBV)感染者会同时感染HDV,因为它是HBV的卫星病毒。HDV感染的治疗颇具挑战性,因为尚无针对HDV的疫苗。虽然已经开发了几种商业PCR和内部检测方法,但由于这些检测方法未得到适当标准化,其结果存在较大差异。由于缺乏用于HDV感染诊断的商业HDV特异性抗体,甚至对于研究工作来说也是如此,因此研究也被推迟。为了填补这一空白,成功地在大肠杆菌系统中表达并纯化了来自本地分离株的HDV I型重组抗原HDAg蛋白,随后在兔体内产生了抗HDAg抗体。在确定并扩增HDV的抗原区域后,将该片段克隆到pET-28a载体中,并在TOP10细胞中表达。在成功表达C末端带有His标签的重组蛋白后,我们使用亲和层析法纯化了该蛋白。通过SDS-PAGE和蛋白质免疫印迹分析证实了HDAg-An蛋白的表达和纯化。经过适当优化,获得了纯度超过90%的HDAg-An蛋白。下一步是用纯化后的蛋白免疫日本白兔。免疫方案包括两次皮下初免剂量各80μg HDAg-An和四次40μg加强剂量,每次加强免疫两周后采血以监测抗体产生。使用定量ELISA技术评估兔血清中抗HDAg抗体的水平。未来,这些抗体可用于开发HDV特异性内部检测方法以及针对本地流行的HDV I型的疫苗,这可能会减轻进口诊断工具和试剂的负担。